KA1-targeted regulatory domain mutations activate Chk1 in the absence of DNA damage

作者: Eun-Yeung Gong , Veronique A. J. Smits , Felipe Fumagallo , Desiree Piscitello , Nick Morrice

DOI: 10.1038/SREP10856

关键词: Protein kinase ABiologyMutationRegulatory siteKinaseBiochemistryPhosphorylationDNA damageCell cycleCHEK1

摘要: The Chk1 protein kinase is activated in response to DNA damage through ATR-mediated phosphorylation at multiple serine-glutamine (SQ) residues within the C-terminal regulatory domain, however molecular mechanism not understood. Modelling indicates a high probability that this region of contains kinase-associated 1 (KA1) small, compact fold found kinases including SOS2, AMPK and MARK3. We introduced mutations into designed disrupt specific structural elements predicted KA1 domain. Remarkably, six seven mutants exhibit constitutive biological activity (Chk1-CA) absence damage, profoundly arresting cells G2 phase cell cycle. Cell cycle arrest induced by selected Chk1-CA depends on catalytic activity, which increased several-fold compared wild-type, key ATR site serine 345 (S345) required. Thus, targeting putative domain confer circumventing need for positive phosphorylation.

参考文章(34)
Joanne Smith, Lye Mun Tho, Naihan Xu, David A. Gillespie, The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Advances in Cancer Research. ,vol. 108, pp. 73- 112 ,(2010) , 10.1016/B978-0-12-380888-2.00003-0
Jennifer Scorah, Meng-Qiu Dong, John R. Yates, Mary Scott, David Gillespie, Clare H. McGowan, A Conserved Proliferating Cell Nuclear Antigen-interacting Protein Sequence in Chk1 Is Required for Checkpoint Function Journal of Biological Chemistry. ,vol. 283, pp. 17250- 17259 ,(2008) , 10.1074/JBC.M800369200
Jiye Shi, Tom L Blundell, Kenji Mizuguchi, FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. Journal of Molecular Biology. ,vol. 310, pp. 243- 257 ,(2001) , 10.1006/JMBI.2001.4762
Michael L. Caparelli, Matthew J. O’Connell, Regulatory motifs in Chk1. Cell Cycle. ,vol. 12, pp. 916- 922 ,(2013) , 10.4161/CC.23881
George Zachos, Michael D Rainey, David AF Gillespie, Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects The EMBO Journal. ,vol. 22, pp. 713- 723 ,(2003) , 10.1093/EMBOJ/CDG060
James R.A. Hutchins, Mike Hughes, Paul R. Clarke, Substrate specificity determinants of the checkpoint protein kinase Chk1 FEBS Letters. ,vol. 466, pp. 91- 95 ,(2000) , 10.1016/S0014-5793(99)01763-9
Ana Kosoy, Matthew J. O'Connell, Regulation of Chk1 by Its C-terminal Domain Molecular Biology of the Cell. ,vol. 19, pp. 4546- 4553 ,(2008) , 10.1091/MBC.E08-04-0444
Fiona C. Leiper, Philippe Leone, Chun Jing, Philip A. Walker, Lesley Haire, John F. Eccleston, Colin T. Davis, Stephen R. Martin, David Carling, Steven J. Gamblin, Bing Xiao, Richard Heath, Peter Saiu, Structural basis for AMP binding to mammalian AMP-activated protein kinase Nature. ,vol. 449, pp. 496- 500 ,(2007) , 10.1038/NATURE06161
M Walker, E J Black, V Oehler, D A Gillespie, M T Scott, Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity. Oncogene. ,vol. 28, pp. 2314- 2323 ,(2009) , 10.1038/ONC.2009.102